✦ LIBER ✦

Adjunctive Therapy with Pramlintide in Patients with Type 1 or Type 2 Diabetes Mellitus

✍ Scribed by Dr. Anna Nogid; Dr. David Q. Pham

Book ID: 115049189
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 109 KB
Volume: 26
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.26.11.1626

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conjunctival flora in patients with type

Conjunctival flora in patients with type 1 or type 2 diabetes mellitus

✍ Habib Bilen; Orhan Ates; Neslihan Astam; Hakan Uslu; Gungor Akcay; Orhan Baykal 📂 Article 📅 2007 🏛 Springer Healthcare Communications 🌐 English ⚖ 270 KB

Therapy with adjunctive doxycycline loca

Therapy with adjunctive doxycycline local delivery in patients with type 1 diabetes mellitus and periodontitis

✍ Antonio Fernando Martorelli de Lima; Cmila Cristina Cury; Daniela Bazan Palioto; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Intensifying insulin therapy in patients

Intensifying insulin therapy in patients with type 2 diabetes mellitus

✍ Irl B. Hirsch 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Pramlintide as an Adjunct to Basal Insul

Pramlintide as an Adjunct to Basal Insulin: Effects on Glycemic Control and Weight in Patients with Type 2 Diabetes Mellitus

✍ Cameron W. Lush; Tamara Darsow; Bei Zhang; Gayle Lorenzi; Juan P. Frias 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 577 KB

Relative hypoleptinemia in patients with

Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus

✍ Roden, M; Ludwig, C; Nowotny, P; Schneider, B; Clodi, M; Vierhapper, H; Roden, A 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Withdrawal of insulin therapy after adju

Withdrawal of insulin therapy after adjunctive treatment with acarbose in a patient with Type 2 diabetes mellitus

✍ Bennett, SMA ;Stewart, MW 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

## Abstract Acarbose has been shown to reduce post‐prandial hyperglycaemia and improve glycaemic control in patients with Type 2 diabetes mellitus. We report its use as an adjunct to established insulin therapy in a 64 year old man with Type 2 diabetes mellitus and secondary failure to treatment wi